top of page

DISRUPT Networking Evening Oct. 11, 2022

We had a kick-off networking event with the DISRUPT team and guests that included directors from Columbia, Mount Sinai, and Einstein/Montefiore Cancer Centers, as well as City College of New York.





Recent Posts

See All

NCI-2021-10597

A Phase 1 Open-Label, Dose-Escalation and Cohort Expansion Study of LUNA18 Monotherapy and Combination Therapy in Patients with Locally...

NCI-2022-10927

A Phase I, Multicenter, Open-label, First-in Human, Dose Escalation and Expansion Study of AZD9592 as Monotherapy and in Combination with...

NCT-05753722

An Open-Label Phase 1 Dose-Escalation and Expansion Study Investigating the Safety,Pharmacokinetics, Pharmacodynamics, and Activity of...

Comments


bottom of page